Resultado de búsqueda
30 de abr. de 2024 · AstraZeneca has admitted that its Covid-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to lawsuits brought by loved ones of ...
10 de abr. de 2021 · The AstraZeneca vaccine is not authorized for use ... Agency said that the vaccine’s labeling should be revised to include the clotting disorder as a “very rare” side effect of the vaccine.
4 de feb. de 2021 · The Zoe app team from King's College London found: 37% experienced some local "after-effects", such as pain or swelling near the site of the injection, after their first dose, rising to about 45% ...
2 de nov. de 2023 · All of these COVID-19 vaccines have met the TGA’s high standards for quality, safety and effectiveness. The TGA closely monitors reports of suspected side effects (also known as adverse events) to the COVID-19 vaccines. This is the most intensive safety monitoring ever conducted of any vaccines in Australia.
30 de may. de 2022 · Overall, following a first dose AstraZeneca vaccine there were 5.8 excess GBS cases per million doses of vaccine, equating to an absolute total excess between January-July 2021 of between 98-140 cases. First-dose Pfizer and Moderna and second-dose of any vaccination showed no excess GBS risk.
28 de abr. de 2024 · AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause a rare side effect, in an apparent about-turn that could pave the way for a multi-million pound ...
30 de abr. de 2024 · Published: 30 Apr 2024, 2:13 PM. Prominent pharmaceutical company AstraZeneca has made a significant admission regarding its Covid-19 vaccine, acknowledging that in very rare cases, it can lead to thrombosis with thrombocytopenia syndrome (TTS), per various media reports. According to a Hindustan Times report, this admission came to light when ...
